About Us

Our Science

Our Proprietary RNAi Drug Discovery Platform, LEAD™,
Enable Us to Efficiently Develop Innovative RNAi Therapeutics
Proprietary GalNAc Platform for Liver Delivery
Our proprietary GalNAc platform enables safe, efficient and precise delivery of RNAi drugs to liver tissue, at an international leading level
Groundbreaking LEAD™ Platform for Extrahepatic Delivery
The LEAD™ platform overcomes extrahepatic delivery barriers, enabling targeted RNAi drug delivery to disease-relevant tissues and cells

Our Pipeline

Advancing RNAi Therapeutics Development
Through Innovation to Fill Unmet Clinical Needs
Our Fast-Growing RNAi Portfolio Covers a Broad Range of Therapeutic Areas
Including Obesity, Cardiometabolic, Autoimmune Diseases

Latest News

  • Home
  • Phone
  • Top